Transforming early clinical development for better outcomes
Greater investments of human and financial resources. More complex study designs. Earlier testing of drugs in patients. All of these are hallmarks of the current evolution in early clinical development. While the challenges are undeniable, they also provide the impetus to refine the development process into one that is smarter and more connected—and that offers a much improved return on your investment.

Improve your probability of success
Great opportunities await those drug developers who are positioned to seize them quickly. Quintiles’ scientific and medical expertise can help you make the strongest possible start, providing insights and high-precision data to inform better go/no-go decisions and arrive at a more robust proof of concept.